Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Downs

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Cancer Immunology, Immunotherapy : CII|September 8, 2010
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancersMelissa A Geller, Sarah Cooley, Peter A Argenta, et al.
Gynecologic Oncology|January 18, 2011
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancerMelissa A Geller, Joseph J Ivy, Rahel Ghebre, et al.
Plant Signaling & Behavior|November 26, 2013
Nitrogen transporter and assimilation genes exhibit developmental stage-selective expression in maize (Zea mays L.) associated with distinct cis-acting promoter motifsChristophe Liseron-Monfils, Yong-Mei Bi, Gregory S Downs, et al.
Cancer|December 7, 2007
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinomaLevi S Downs, Patricia L Judson, Peter A Argenta, et al.
Journal of the National Cancer Institute|June 20, 2015
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 TrialAshley S Felix, Louise A Brinton, D Scott McMeekin, et al.
BMJ Open|September 4, 2023
Understanding Heterogeneity in Patients' Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster AnalysisBetty Hsiao, Julie S Downs, Mandy Lanyon, et al.
Gynecologic Oncology|March 15, 2013
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trialLouise A Brinton, Ashley S Felix, D Scott McMeekin, et al.
International Journal of Obesity (2005)|July 27, 2013
Vigorous physical activity and longitudinal associations with cardiometabolic risk factors in youthV Carson, R L Rinaldi, B Torrance, et al.
Cytotherapy|September 21, 2010
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancerMelissa A Geller, Sarah Cooley, Patricia L Judson, et al.
Journal of Pediatric and Adolescent Gynecology|November 12, 2017
Video Intervention to Increase Perceived Self-Efficacy for Condom Use in a Randomized Controlled Trial of Female AdolescentsJulie S Downs, Amie M Ashcraft, Pamela J Murray, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Cancer Immunology, Immunotherapy : CII|September 8, 2010
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancersMelissa A Geller, Sarah Cooley, Peter A Argenta, et al.
Gynecologic Oncology|January 18, 2011
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancerMelissa A Geller, Joseph J Ivy, Rahel Ghebre, et al.
Plant Signaling & Behavior|November 26, 2013
Nitrogen transporter and assimilation genes exhibit developmental stage-selective expression in maize (Zea mays L.) associated with distinct cis-acting promoter motifsChristophe Liseron-Monfils, Yong-Mei Bi, Gregory S Downs, et al.
Cancer|December 7, 2007
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinomaLevi S Downs, Patricia L Judson, Peter A Argenta, et al.
Journal of the National Cancer Institute|June 20, 2015
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 TrialAshley S Felix, Louise A Brinton, D Scott McMeekin, et al.
BMJ Open|September 4, 2023
Understanding Heterogeneity in Patients' Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster AnalysisBetty Hsiao, Julie S Downs, Mandy Lanyon, et al.
Gynecologic Oncology|March 15, 2013
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trialLouise A Brinton, Ashley S Felix, D Scott McMeekin, et al.
International Journal of Obesity (2005)|July 27, 2013
Vigorous physical activity and longitudinal associations with cardiometabolic risk factors in youthV Carson, R L Rinaldi, B Torrance, et al.
Cytotherapy|September 21, 2010
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancerMelissa A Geller, Sarah Cooley, Patricia L Judson, et al.
Journal of Pediatric and Adolescent Gynecology|November 12, 2017
Video Intervention to Increase Perceived Self-Efficacy for Condom Use in a Randomized Controlled Trial of Female AdolescentsJulie S Downs, Amie M Ashcraft, Pamela J Murray, et al.
Pageof 22